GLP-1 drugs an option for kids with obesity: WHO

The World Health Organization (WHO) has released its first guidelines for managing childhood obesity, introducing a cautious approach to medical interventions. While the WHO suggests GLP-1 drugs only for those aged 10-19 when lifestyle changes fail, other regions like Canada adopt a more aggressive strategy, considering medication for children as young as 12 from the start.